From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway. [electronic resource]
- Drug discovery today 06 2016
- 1027-36 p. digital
Publication Type: Journal Article; Review
1878-5832
10.1016/j.drudis.2016.04.011 doi
Animals Antibodies, Monoclonal--therapeutic use B7-H1 Antigen--antagonists & inhibitors Humans Programmed Cell Death 1 Receptor--antagonists & inhibitors Signal Transduction--drug effects